Clinical Trial: A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Conditions.

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922070) titled 'A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Conditions.' on Oct. 12.

Brief Summary: To investigate the pharmacokinetics and evaluate the bioequivalence of a single oral dose of the test preparation Olanzapine Samidofen Tablets versus the reference preparation Olanzapine Samidofen Tablets (LYBALVI(R)) in healthy adult subjects under fasting conditions.

Study Start Date: Oct. 23, 2025

Study Type: INTERVENTIONAL

Condition: Bipolar I Disorder

Intervention: DRUG: Test Olanzapine Samidofen Tablets

The Olanzapine Samidofen Tablets, with a specification of 5 mg olanzapine and 10 mg samidofe...